Navigation Links
Adeona's Alzheimer's Disease Pivotal Clinical Study Results Abstract Accepted for Presentation at the American Academy of Neurology's 63rd Annual Meeting
Date:2/8/2011

ANN ARBOR, Mich., Feb. 8, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that an abstract on the Company's pivotal clinical trial of its zinc and cysteine-based product candidate being evaluated in patients with Alzheimer's disease and mild cognitive impairment has been accepted for presentation at the 2011 American Academy of Neurology Annual Meeting in April. The abstract will provide top line clinical trial results, as well as the rationale and design of the pivotal study.

Diana Pollock, M.D., Lead Principal Investigator of the trial at Morton Plant Neuroscience Institute on the campus of Morton Plant Hospital, is the first author on the abstract titled "Clinical Trial Results of the First Controlled Clinical Trial of Zinc-Based Therapy for Alzheimer's Disease and Mild Cognitive Impairment." The poster presentation will be held from 2:00 to 6:30 p.m. on April 14, 2011 at the Hawaii Convention Center in Honolulu, Hawaii. Due to conference restrictions with regard to the embargo policy relating to clinical trial results, Adeona plans to present the results of its pivotal clinical trial during this conference and distribute a concurrent press release.

Adeona also announced that "reaZin™" has been adopted as the new trademark for its zinc and cysteine-based oral tablet currently under development as a prescription medical food for the dietary management of Alzheimer's disease and mild cognitive impairment. Previously, Adeona's zinc and cysteine-based product candidate was called Zinthionein.

reaZin was selected as the new trademark as it is a homophone to the word reason, a high level cognitive function affected by Alzheimer's disease that Adeona's product candidate seeks to address. In addition, the "Zin" root is suggestive of the p
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
7. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)...  CipherHealth, a leading provider of innovations and solutions ... representatives to the Nepalese American Nursing Association to donate ... to Nepal to aid in ... In addition to helping fund the travel costs for ... much-needed medical supplies for the mission.  ...
(Date:5/5/2015)... 2015   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" ... today that it will release its full financial results for ... 11 th before the open, followed by a conference ... and business outlook. Participants should call (888) 243-4451 ... and request the InspireMD call. A live webcast of the ...
(Date:5/5/2015)... Inc. (NASDAQ:  TROV), a developer of cell-free molecular ... three months ended March 31, 2015. ... clinical results at ASCO GI, AACR, and the ... Monitoring platform,s ability to detect and monitor driver ... Antonius Schuh, Ph.D., chief executive officer of Trovagene. ...
Breaking Medicine Technology:Five Nurses and Medical Supplies En Route to Nepal With Donation Assistance from CipherHealth 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6
... Capital, Inc., a wholly owned subsidiary of Merriman Holdings, ... it will serve as the Designated Advisor for Disclosure ... transitions from trading on the NYSE Amex and begins ...     Radient Pharmaceuticals is dedicated to ...
... Sirnaomics, Inc. ( www.sirnaomics.com ) announced today that ... Guangdong Zhongsheng Pharmaceutical Co. Ltd., a Chinese pharmaceutical ... 002317). The partnership will focus on development of ... retinopathy and age-related macular degeneration.  This is the ...
Cached Medicine Technology:Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX 2Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX 3Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX 4Sirnaomics Seals a Second Partnership Deal with a Chinese Pharmaceutical Company for Developing siRNA Therapeutics 2Sirnaomics Seals a Second Partnership Deal with a Chinese Pharmaceutical Company for Developing siRNA Therapeutics 3
(Date:5/6/2015)... 2015 LINET Americas has been awarded ... the small business category. The award was given for ... Award is given on an annual basis to foreign ... contributions to philanthropy. Since 1998, the Charlotte International ... the Mayor’s International Community Awards. The award was presented ...
(Date:5/6/2015)... 06, 2015 “ Radiation Island ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... best graphic games on iOS. , Touted as one of ... It’s loved by users, which is obvious because of its ...
(Date:5/5/2015)... With ProPoint: Hand Drawn, users can point, underline, ... X . With ProPoint: Hand Drawn, users can also ... customize each preset all with a click of a mouse. ... fully customizable effect presets all within Final Cut Pro X. ... underlines, and more. , ProPoint: Hand Drawn on-screen controls ...
(Date:5/5/2015)... The Journal of Pain Research ... to improve the management of chronic non-cancer pain ... ACCORD program ” , As corresponding author Professor ... patients and family members, managers, and researcher, identified ... gap, “work in silos”, lack of awareness regarding ...
(Date:5/5/2015)... 2015 “Given that Hispanics are one in ... CDC report are a major step in the arsenal of ... For the past 30 years, data have accumulated that the ... we see the urgency and the need to create new ... outcomes for all,” said Jane L. Delgado, PhD, MS, President ...
Breaking Medicine News(10 mins):Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2
... Clarient, Inc. (Nasdaq: CLRT ... pathologists, oncologists and the pharmaceutical industry, today announced that the Company ... Investments reconstitutes its comprehensive set of U.S. and global equity indices ... June 12 on www.russell.com . , , ...
... to hit market in September , , BOSTON, June 29 ... Times bestselling author and renowned wellness coach from NBC,s ... of weight-loss products in partnership with ThinCare(TM) International, LLC. The new ... Drug Stores Marketplace in Boston, Massachusetts on June 29, 2009. Scientifically ...
... , ... keep your pet healthy and happy and is more likely to avoid serious and costly health ... , ... pet health care can prevent expensive vet bills in the future, pet owners are reminded, as everyone ...
... ... an authorized representative agreement with SupplyCore Middle East (SCME). The agreement allows SCME to ... Medical decontamination equipment throughout the Middle East and North Africa (MENA). , ... (Vocus) June 29, 2009 -- ...
... ... MD Now Urgent Care: MD Now Urgent Care Medical Centers of Palm Beach County Florida has ... by the Urgent Care Association of America. , ... Palm Beach Gardens, FL (PRWEB) June 29, 2009 -- MD Now Urgent Care Medical Centers ...
... ... new coalition under the leadership of Matthias Rath, MD, is spearheading an online grass roots ... the rights of Americans to access safe, science-based, natural health alternatives. , ... Santa Clara, CA (PRWEB) June 29, 2009 -- ...
Cached Medicine News:Health News:Clarient Set to Join Russell 3000 Index 2Health News:Clarient Set to Join Russell 3000 Index 3Health News:Clarient Set to Join Russell 3000 Index 4Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 2Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 3Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 2Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 3Health News:Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa 2Health News:Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa 3Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 2Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 4Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 5
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... Lead is designed for temporary atrial and ...
Carbo-Seal Valsalva AAP is the first valved graft to replicate the natural Sinus of Valsalva, encouraging the natural formation of systolic vortices....
... primary indication for this technique is ... organic. Indications for tricuspid repair are ... insufficiency as diagnosed by angiography and ... treatment. In patients with an irreversible ...
Current annuloplasty rings and bands are designed for symmetric dilatation. The IMR ETlogix ring is the first asymmetric ring designed to treat asymmetric dilatation....
Medicine Products: